Periodic Reporting for period 3 - Vacc-iNTS (Advancing a GMMA-based vaccine against invasive non-typhoidal salmonellosis through Phase 1 trial in Europe and sub-Saharan Africa)

Invasive non-typhoidal Salmonella (iNTS) infections are a serious health concern causing about 535,000 cases per year, of which more than 400,000 were in sub-Saharan Africa (sSA), where the highest incidence is observed (34.5 cases per 100,000 person-years). Commonly affecting...